Category Archives: Brain Injury Treatment

November 5, 2020 Studies using repetitive transcranial magnetic stimulation (rTMS), a noninvasive technique, to help veterans and active-duty service members living with depression, post-traumatic stress disorder (PTSD), and other lasting consequences of concussion have shown promise. However, theres an urgent need for studies designed to address the unique patterns of post-concussion symptoms seen in military populations, concludes a review in the November/December issue of the Journal of Head Trauma Rehabilitation (JHTR) Continue reading →

This story is part of our specialVeterans Day section, which will run in print Sunday, Nov. 8 Continue reading →

PITTSBURGH--(BUSINESS WIRE)--Noveome Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on developing next-generation biologics for the promotion and restoration of cellular integrity of inflamed or damaged tissues, announced that Larry Brown, Sc.D., the companys Executive Vice President and Chief Scientific Officer, will present a talk entitled, Neuroprotection by Intranasal ST266, an Amnion Multipotent Progenitor Cell-Derived Secretome at the virtual 10th Annual Traumatic Brain Injury Conference at 1:35 pm EST on November 03, 2020. Dr. Brown will discuss the development of Noveomes neuroprotective program which is evaluating intranasal nose-to-brain delivery of its novel platform biologic, ST266, to treat traumatic brain injury and optic nerve/retinal diseases and injuries. Continue reading →

Paula Grisanti, Opinion contributor Published 6:20 a.m. ET Nov. Continue reading →

It was her childhood peanut allergy that first sparked senior Ayesha Ngs fascination with the human body. To see this severe reaction happen to my body and not know what was happening that made me a lot more curious about biology and living systems, Ng says. She didnt exactly plan it this way Continue reading →

Radiology has assumed enormous significance in diagnosis and prognostication during the COVID-19 pandemic and lakhs of people are slowly but surely becoming aware of HRCT Scan, a diagnostic test conducted by the radiology department. Although people seldom interact directly with the radiologists, the role that the latter plays before COVID-19 is confirmed as well as during treatment post recovery is undeniable. Their contribution has become more pronounced during the pandemic. Continue reading →

Neurological devices industry is growing at a significant rate due to increase in the prevalence of neurological injuries and diseases. Neurological devices may be invasive in nature such as intracranial pressure monitors, which are used in serious cases. Non-invasive brain trauma monitoring devices refer to the devices that help to monitor neural and electrical activity and pressure enclosing the brain. Continue reading →

Post-9/11 veterans have alarmingly high rates of insomnia disorder, according to a Department of Veterans Affairs San Diego Healthcare System study. More than half of those studied had the disorder, according to a recent VA blog post. Continue reading →

Newswise Traumatic brain injury (TBI)is a leading cause of cognitive impairment that affects millions of people worldwide. Despite growing awareness about the debilitating and lifelong progressive consequences of TBI, there are currently no treatments that slow the deteriorative process. TBI survivors are currently treated with extensive physical and cognitive rehabilitation, accompanied by medications that may mitigate symptoms yet do not halt or slow neurodegeneration Continue reading →

SAN DIEGO, Oct. 21, 2020 /PRNewswire/ -- Oxeia Biopharmaceuticals Inc., a clinical stage biotech company developing a drug treatment for concussion to address underlying neuro-metabolic dysfunction and axonal injury, announced today initiation of a Phase 2 clinical trial of OXE103 for treating concussion. The Phase 2 clinical study is being conducted by Dr Continue reading →